FDA Clearance Tracker · P100047-S163
HeartWare Left Ventricular Assist System
Last checked: Nov 20, 2026Latest source record: Nov 18, 2020 (this decision)Source: openFDAMethods & limitations
Decided
Nov 18, 2020
Approved
Time to decision
180 days
Received May 22, 2020. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P100047-S163
- Device name
- HeartWare Left Ventricular Assist System
- Applicant
- Medtronic
- Applicant location
- Mounds View, MN
- Received
- May 22, 2020
- Decided
- Nov 18, 2020
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P100047
Device type
- Device type
- Ventricular (assist) bypass (DSQ)
- Device class
- Class III
- Specialty
- Cardiology
FDA's approval statement
As written in FDA's record.
Approval for changes to the Instructions for Use and Patient Manual as a result of remediation activities.
Source documents
Other decisions for Medtronic
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K262716 · Decided Nov 6, 2026 · 98 days after receipt
Device type: Neurological Stereotaxic Instrument (HAW) · Neurology & Neurosurgery
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.